AP
NVO

Atwood & Palmer’s Novo Nordisk NVO Stock Holding History

Atwood & Palmer’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2K Sell
400
-88
-18% -$3.78K ﹤0.01% 328
2026
Q1 		$17.9K Hold
488
– – ﹤0.01% 334
2025
Q4 		$24.8K Hold
488
– – ﹤0.01% 304
2025
Q3 		$27.1K Sell
488
-249
-34% -$14.6K ﹤0.01% 303
2025
Q2 		$50.9K Buy
737
+178
+32% +$12.1K ﹤0.01% 240
2025
Q1 		$38.8K Hold
559
– – ﹤0.01% 241
2024
Q4 		$48.1K Hold
559
– – ﹤0.01% 221
2024
Q3 		$66.6K Sell
559
-22
-4% -$2.93K ﹤0.01% 207
2024
Q2 		$82.9K Buy
581
+181
+45% +$24K 0.01% 199
2024
Q1 		$51.4K Hold
400
– – ﹤0.01% 210
2023
Q4 		$41.4K Buy
400
+150
+60% +$14.8K ﹤0.01% 232
2023
Q3 		$22.7K Buy
+250
New +$22K ﹤0.01% 264
2017
Q4 		– Sell
-8,800
Closed -$212K – 300
2017
Q3 		$212K Sell
8,800
-1,300
-13% -$29.4K 0.03% 125
2017
Q2 		$217K Sell
10,100
-64,784
-87% -$1.31M 0.03% 122
2017
Q1 		$1.28M Sell
74,884
-327,852
-81% -$5.71M 0.21% 57
2016
Q4 		$7.22M Sell
402,736
-88,650
-18% -$1.61M 1.3% 28
2016
Q3 		$10.2M Sell
491,386
-1,380
-0.3% -$34.2K 1.86% 22
2016
Q2 		$13.3M Buy
492,766
+21,900
+5% +$601K 2.39% 17
2016
Q1 		$12.8M Buy
470,866
+470,036
+56,631% +$12.6M 2.27% 19
2015
Q4 		$24K Hold
830
– – ﹤0.01% 258
2015
Q3 		$23K Buy
830
+600
+261% +$17K ﹤0.01% 255
2015
Q2 		$6K Buy
+230
New +$6.47K ﹤0.01% 324

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Atwood & Palmer's NVO Position: Q2 2026 in Review

Atwood & Palmer reduced its Novo Nordisk (NVO) stake by 18% in Q2 2026, selling an estimated $3.78K and leaving 400 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #328.

Atwood & Palmer first reported a position in NVO in Q2 2015 and has held it in 22 quarters since. The position peaked at $13.3M in Q2 2016. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Atwood & Palmer held 400 shares of Novo Nordisk worth $19.2K as of Q2 2026.
  • Atwood & Palmer sold 88 Novo Nordisk shares in Q2 2026, an estimated $3.78K.
  • Novo Nordisk made up ﹤0.01% of Atwood & Palmer's portfolio in Q2 2026, its #328 holding.
  • Atwood & Palmer first reported a position in Novo Nordisk in Q2 2015 and has held it in 22 quarters since.
  • Atwood & Palmer's Novo Nordisk position peaked at $13.3M in Q2 2016.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.